Evidence map›Paper›PMID 35456990›Full record

ReviewInternational journal of molecular sciences2022

Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection.

Marcin Janecki, Michał Graczyk, Agata Anna Lewandowska, Łukasz Pawlak

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Is There a Place for Cannabinoids in Asthma Treatment?International journal of molecular sciences · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Antiviral activities of hemp cannabinoids.Clinical science (London, England : 1979) · 2023
    Article
  11. Review
  12. CBD resistantFrontiers in medicine · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Marcin JaneckiDepartment of Palliative Care and Palliative Medicine, Silesian Medical University in Katowice, 40-752 Katowice, Poland.ORCID 0000-0002-0946-8844
Michał GraczykDepartment of Palliative Care, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 87-100 Toruń, Poland.
Agata Anna Lewandowska10th Military Research Hospital and Polyclinic in Bydgoszcz, 85-681 Bydgoszcz, Poland.ORCID 0000-0002-0966-8467
Łukasz PawlakCollegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 87-100 Toruń, Poland.
Nicolaus Copernicus University · PLMedical University of Silesia · PLUniversity of Bydgoszcz · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic caused by the SARS-CoV-2 virus made it necessary to search for new options for both causal treatment and mitigation of its symptoms. Scientists and researchers around the world are constantly looking for the best therapeutic options. These difficult circumstances have also spurred the re-examination of the potential of natural substances contained in

Indexed as

CannabinoidsCannabisCOVID-19 Drug TreatmentAnti-Inflammatory AgentsAntiviral AgentsHumansPandemicsSARS-CoV-2Anti-Inflammatory AgentsAntiviral AgentsCannabinoidsanti-inflammatoryantiviralcannabinoidsCannabis sativaCBDCOVID-19SARS-CoV-2terpene

Identifiers

PMID35456990
PMCPMC9025270
OpenAlexW4223485001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.